Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SMA | QUBT |
|---|---|---|
| Price | $32.47 | $7.94 |
| Change today | ▼ 0.12% | ▼ 2.93% |
| Market cap | $1.80B | $1.80B |
| Return, 3 months | +1.0% | -8.6% |
| Return, year to date | +9.0% | -22.6% |
| Return, 1 year | -2.8% | -64.2% |
| P/E (TTM) | 62.3 | -198.5 |
| P/B | 1.6 | 1.1 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 4.93% | – |
| Revenue growth (YoY, latest qtr) | +18.6% | +82.8% |
| Net profit growth (YoY) | +351.6% | +72.8% |
| Gross margin | 59.8% | 9.8% |
| Operating margin | 21.8% | -7,489.3% |
| Net margin | 9.4% | -2,738.1% |
| Return on equity | 2.4% | – |
| Analyst target vs. price | +11.4% | +146.5% |
| Analyst buy share | 50% | 71% |
| RSI (14) | 52 | 40 |
| 30-day volatility | 20.1% | 47.3% |
| Max drawdown, 1 year | -20.9% | -74.4% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
